Search
Clinical Trial
A PHASE 1, OPEN-LABEL, DOSE ESCALATION AND DOSE EXPANSION STUDY FOR LNCB74, A B7-H4 TARGETED ANTIBODY DRUG CONJUGATE, AS MONOTHERAPY IN PARTICIPANTS WITH ADVANCED SOLID TUMORS
… MONOTHERAPY IN PARTICIPANTS WITH ADVANCED SOLID TUMORS I Zsiros, Emese This is an open-label, phase 1, dose escalation …
Clinical Trial
A Phase 1, Open-Label, Dose-Escalation Study Evaluating the Safety and Tolerability of GB-5267, an IL-18 Armored CAR T Cell Product Targeting MUC16, in Patients with Platinum-Resistant Ovarian Cancer
… in Patients with Platinum-Resistant Ovarian Cancer I Zsiros, Emese This phase 1 study evaluates the safety, …
News
Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer
Page with Layout
Faculty Mentors
… Sai Yendamuri, MD, MBA, FACS Thoracic Surgery Emese Zsiros, MD, PhD, FACOG Gynecologic Oncology University at …
Cancer Types
Recurrent Ovarian Cancer
Research
Roswell Park-University of Chicago Ovarian Cancer SPORE Clinical Trials
… contact the Principal Investigator (Clinical), Emese Zsiros, MD, PhD, FACOG . Upcoming clinical trials A Phase … contact the Principal Investigator (Clinical), Emese Zsiros, MD, PhD, FACOG . Upcoming clinical trials A Phase …
Clinical Trial
NRG-GY032: A Phase II Study of Tailored Adjuvant Therapy in Pole-Mutated and p53-Wildtype/NSMP Early-Stage Endometrial Cancer (RAINBO BLUE & TAPER)
Roswell Park Oncology Year-In-Review: What Changed, What’s Next
… Oncology Prantesh Jain, MD, FACP Medical Oncology Emese Zsiros, MD, PhD, FACOG Gynecologic Oncology Saby George, MD, … Jain, MD 8:05-8:45 a.m. Gynecologic Oncology Emese Zsiros, MD 8:45-9:30 a.m. Head and Neck Cancer Aarti Bhatia, …
Blog Post
Does your gut biome affect your response to immunotherapy?
… The study was led by Principal Investigator Emese Zsiros, MD, PhD, FACOG , Chair of Gynecologic Oncology. All … the biological mechanisms behind them,” says Dr. Zsiros. “We observed that patients who experienced a … conditions. In the more immediate future, Drs. Zsiros and Rosario are exploring Dielma fastidiosa, a …